Genmab A (GMAB) Total Non-Current Liabilities (2023 - 2026)
Genmab A (GMAB) recorded Total Non-Current Liabilities of $5.42 billion in the quarter ended Jun 30, 2026, down 1.8% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A reported Total Non-Current Liabilities of $5.6 billion, up 950.5% from the prior year.
- Annual Total Non-Current Liabilities has increased for three straight years, with a five-year compound annual growth rate of 128.8% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Total Non-Current Liabilities came in at $533 million in the year ended Dec 31, 2024 (+201.1%), $177 million in the year ended Dec 31, 2023 (+87.1%), $94.62 million in the year ended Dec 31, 2022 (-3.0%) and $97.51 million in the year ended Dec 31, 2021 (+9.2%).
- Quarterly Total Non-Current Liabilities has ranged from $91.76 million in the quarter ended Mar 31, 2022 to $5.6 billion in the quarter ended Dec 31, 2025 over the past five years.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 215.4% in the quarter ended Dec 31, 2024, against a decline of 87.2% in the quarter ended Sep 30, 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Genmab A | 2.56 Bn | -2.81 Bn | 1.07 Bn | 5.42 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.42 Bn |
| Mar 31, 2026 | 5.52 Bn |
| Dec 31, 2025 | 5.60 Bn |
| Sep 30, 2025 | 529.00 Mn |
| Jun 30, 2025 | 533.00 Mn |
| Mar 31, 2025 | 534.00 Mn |
| Dec 31, 2024 | 533.00 Mn |
| Dec 31, 2023 | 177.00 Mn |
| Jan 1, 2023 | 146.00 Mn |
API Access
Genmab A Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();